Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

BACKGROUND: Recombinant factor VIIa (rFVIIa) may be used for rapid hemostasis in life-threatening hemorrhage. In warfarin-associated intracerebral hemorrhage (wICH), FVIIa use is controversial and may carry significant thromboembolic risks. We compared incidence of baseline thromboembolic risk facto...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: H-Y, Chou Sherry, Xuemei, Cai, G, Konigsberg Rachael, M, Bresette Linda, V, Henderson Galen, A, Sorond Farzaneh, K, Feske Steven
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538560/
https://ncbi.nlm.nih.gov/pubmed/23241423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-158
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak